Using genetics of human fat cells to predict response to anti-diabetes drugs

Researchers have demonstrated — using fat cells derived from human stem cells — that individual genetic variation can be used to predict whether the TZD rosiglitazone will produce the unwanted side effect of increasing cholesterol levels in certain individuals.

Read more…

U Penn

Stem Cell



By |2019-01-12T20:06:20+00:00January 12th, 2019|

Leave A Comment